A-mRNA landscapes between mouse and human cortical neurogenesis reveals enrichment of human-specific m 6 A tagging of transcripts related to brain-disorder risk genes. Our study identifies an epitranscriptomic mechanism in heightened transcriptional coordination during mammalian cortical neurogenesis.
A regulates mammalian brain development is unknown. Here, we show that m 6 A depletion by Mettl14 knockout in embryonic mouse brains prolongs the cell cycle of radial glia cells and extends cortical neurogenesis into postnatal stages. m 6 A depletion by Mettl3 knockdown also leads to a prolonged cell cycle and maintenance of radial glia cells. m 6 A sequencing of embryonic mouse cortex reveals enrichment of mRNAs related to transcription factors, neurogenesis, the cell cycle, and neuronal differentiation, and m 6 A tagging promotes their decay. Further analysis uncovers previously unappreciated transcriptional prepatterning in cortical neural stem cells. m 6 A signaling also regulates human cortical neurogenesis in forebrain organoids. Comparison of m
INTRODUCTION
Proper development of the nervous system is critical for its function, and deficits in neural development have been implicated in many brain disorders, such as microcephaly, autistic spectrum disorders, and schizophrenia (Jamuar and Walsh, 2015; Taverna et al., 2014) . In the embryonic mouse cortex, radial glia cells (RGCs) function as neural stem cells, sequentially giving rise to neurons residing in different cortical layers and then switching to glial production before their depletion during early postnatal stages (Taverna et al., 2014) . Such a precise and predictable developmental schedule requires a highly coordinated genetic program (Okano and Temple, 2009) . Indeed, previous studies have revealed transcriptional cascades that orchestrate the dynamics of mammalian cortical neurogenesis (Martynoga et al., 2012; Miller et al., 2014; Nord et al., 2015) . Recent discoveries of widespread mRNA chemical modifications (Zhao et al., 2017a) raise the question of whether this mechanism plays any regulatory role in cortical neurogenesis.
Modified nucleotides in mRNAs were initially discovered over 40 years ago, but little was known about the extent, transcript identities, and potential functions of various reversible chemical modifications until very recently (Zhao et al., 2017a) . Highthroughput sequencing approaches have revealed a dynamic ''epitranscriptome'' landscape for many mRNA modifications in various organisms, including N 6 -methyladenosine (m 6 A),
A in mRNA metabolism, from processing in the nucleus to translation and decay in the cytoplasm (Zhao et al., 2017a) . The field has just started to investigate physiological functions of m 6 A. For example, Mettl3
or Mettl14 knockdown reduces m 6 A levels and decreases selfrenewal of primed mouse embryonic stem cells (mESCs) (Wang et al., 2014a) , whereas Mettl3 knockout naive mESCs exhibit improved self-renewal and impaired differentiation due to dysregulated decay of m 6 A-tagged transcripts, such as Nanog (Batista et al., 2014; Geula et al., 2015) .
Identification of the molecular machinery mediating m 6 A mRNA methylation provides an entry point to explore physiological functions of this pathway in vivo. Studies of Drosophila development showed that m 6 A methylation regulates sex determination and neuronal functions by modulating mRNA splicing (Haussmann et al., 2016; Lence et al., 2016) . In zebrafish embryos, m 6 A-tagging promotes clearance of maternal mRNAs and maternal-to-zygotic transition (Zhao et al., 2017e) . In mice, germline Mettl3 deletion results in early embryonic lethality (Geula et al., 2015) . Nothing is known about the role of m 6 A signaling during mammalian embryonic brain development in vivo. Here, we used the Mettl14 conditional knockout (cKO) mouse as a model to examine m 6 A function in embryonic cortical neurogenesis in vivo. We further investigated underlying cellular and molecular mechanisms. Finally, we extended our analysis to human embryonic cortical neurogenesis using induced pluripotent stem cell (iPSC)-derived forebrain organoids and compared m 6 A-mRNA landscapes between mouse and human cortical neurogenesis. Together, our results reveal critical epitranscriptomic control of mammalian cortical neurogenesis and provide insight into mechanisms underlying this highly coordinated developmental program.
RESULTS

Nervous System Mettl14 Deletion Extends Cortical Neurogenesis into Postnatal Stages
We first investigated the expression pattern of molecular players mediating m 6 A signaling during mouse embryonic cortical neurogenesis. Mining the recently published singlecell RNA-sequencing (RNA-seq) dataset of RGCs and their progeny (Telley et al., 2016) revealed the highest Mettl14 expression in RGCs and relatively constant levels of m 6 A methyltransferase components (Mettl3 and Wtap), demethylases (Fto and Alkbh5), and m 6 A readers (Ythdf2 and Ythdf3) during neurogenesis ( Figure S1A ). We next conditionally deleted Mettl14 in the developing mouse nervous system starting at embryonic day 11.5 (E11.5) using the Nestin-Cre;Mettl14
f/f cKO model ( Figure S1B ). We confirmed Mettl14 deletion at the protein level with western blot analysis of E17.5 brains ( Figure S1B ). The cKO animals were smaller by postnatal day 5 (P5) than wild-type (WT) littermates, and all cKO animals died before P25 ( Figures S1C and S1D) . Thus, the function of m 6 A molecular machinery in the nervous system is indispensable for life in the mammalian system.
We then examined cortical structures at P5. cKO mice exhibited enlarged ventricles with an adjacent dense layer of cells that resembled the embryonic germinal zone ( Figure 1A ). Immunohistological analysis showed the presence of Pax6 + and Nestin + cells with radial fibers along the ventricle in cKO mice, but not in WT mice (Figures 1A and 1B) . During mouse cortical development, Pax6
+ RGCs are largely depleted by P5 (Dwyer et al., 2016) . In contrast, a substantial number of Pax6 + cells were present in cKO mice at P5 ( Figure 1C ). Neurogenic Pax6 + RGCs give rise to intermediate progenitor cells (IPCs) expressing Tbr2/ Eomes (Englund et al., 2005) . The presence of Pax6 + cells in cKO mice was accompanied by Tbr2 + IPCs, which were absent in WT mice by P5 ( Figures 1D and 1E ). To confirm that cortical neurogenesis continued postnatally, we pulsed animals with ethynyldeoxyuridine (EdU) at P5 and analyzed 2 days later. Significant numbers of EdU + Pax6 + proliferating RGCs, EdU + Tbr2 + IPCs, and EdU + Tbr2 + TuJ1 + neuroblasts were present in cKO mice, but very few were present in WT littermates (Figures 1F and 1G) . These results indicate that cKO mice maintain neurogenic RGCs with extended cortical neurogenesis into postnatal stages.
To further characterize the impact of Mettl14 deletion on cortical development, we examined neuronal subtype and glia production. We pulsed animals with EdU at E15.5 and examined them at P5. Compared to WT littermates, cKO mice exhibited a significantly decreased number of EdU + Satb2 + neurons, suggesting a deficit in producing late-born upper-layer neurons (Figures 1H and 1I) . Direct measurement of the number of different cortical neuron subtypes also showed a reduced number of Satb2 + upper-layer neurons but comparable numbers of Tbr1 + and Ctip2/Bcl11b + lower-layer early-born neurons in P5 cKO mice ( Figures S1E and S1F ). On the other hand, Ctip2
+ neurons were reduced in number in the E17.5 cKO cortex, suggesting a delay in the production of neuron subtypes of different cortical layers rather than differentiation deficits (Figures S1G and S1H) . In addition, we observed a significant decrease in the number of s100b + astrocytes in cKO mice at P5 ( Figures 1J and 1K ).
Together, these results indicate that Mettl14 function is critical for proper temporal progression of neurogenesis and gliogenesis during mouse cortical development in vivo.
Mettl14 Deletion in Neural Progenitor Cells Leads to Protracted Cell-Cycle Progression
Given the well-defined temporal progression of cortical neurogenesis from RGCs (Okano and Temple, 2009 ), we suspected that there could be RGC deficits during embryonic stages in cKO mice. Interkinetic nuclear migration (INM), the periodic movement of the cell nucleus in phase with cell-cycle progression, is a common feature of developing neuroepithelial (Taverna et al., 2014) . We pulsed animals with EdU at E17.5 to label cells in S phase and followed positions of nuclei in EdU + Pax6 + RGCs (Figure 2A ). While there was no difference at 0.5 hr after EdU labeling, nuclei of labeled RGCs were positioned further away from the ventricular surface at 6 hr in cKO mice than in WT mice ( Figure 2B ), suggesting delayed INM and potential cell-cycle deficits. To directly examine the S to M phase transition of the cell cycle, we analyzed expression of phospho-histone 3 (pH3), an M phase marker, 2 hr after EdU labeling ( Figure 2C Figure 2D ). To examine the cell-cycle exit of proliferating neural progenitors, we analyzed expression of Ki67 (a proliferation marker) 24 hr after EdU labeling ( Figure 2E ). We found a significant decrease in the percentage of Ki67-negative cells among EdU + cells in cKO mice, indicating a delay in cell-cycle exit ( Figure 2F) .
To address the cell-intrinsic effect of Mettl14 deletion on cellcycle progression, we performed time-lapse imaging of individual cortical neural progenitor cells (NPCs) cultured from E13.5 mouse cortex. We used a dual-reporter system with nuclear localized H2B-mCherry and a GFP-tagged Cdk2 substrate, DNA helicase B (DHB) (Spencer et al., 2013) . Cdk2 becomes active during the G 1 to S transition and phosphorylates DHB-GFP, which is then translocated from the nucleus to the cytoplasm. Therefore, the presence of GFP in the mCherry + nucleus indicates cells in G 1 phase, whereas translocation to the cytoplasm indicates S phase initiation, and continual buildup of in white boxes are shown at a higher magnification. Scale bars represent 500 mm (A, top), 50 mm (A, bottom), and 100 mm (B). Values in (C) represent mean ± SEM (n = 4-7; ***p < 0.001; *p < 0.05; unpaired Student's t test).
(D and E) Presence of IPCs in P5 cKO cortices. Shown are sample confocal images (D; scale bars, 100 mm) and quantification (E). Values represent mean ± SEM (n = 6; ***p < 0.001; **p < 0.01; unpaired Student's t test Quantification of EdU + cells with different markers is shown in (G). Values represent mean ± SEM (n = 6; ***p < 0.001; unpaired Student's t test).
(H-K) Reduced production of upper-layer neurons and astrocytes in cKO cortices. Pregnant mice were injected with EdU at E15.5 and analyzed at P5. Shown are sample confocal images (H and J; scale bars, 100 mm) and quantification (I and K). Values represent mean ± SEM (n = 6; ***p < 0.001; unpaired Student's t test). See also Figure S1 .
cytoplasmic GFP occurs until mitosis ( Figure S2A ). Quantification of the length between sequential mitoses showed an increase of the total cell-cycle length in Mettl14 cKO NPCs (Figures 2G and 2H; Movies S1 and S2) . Further analysis of different cell-cycle phases revealed a specific increase of the S-G 2 -M phases in the absence of Mettl14 but no difference in the G 1 phase ( Figures 2I and 2J ).
To quantify cell-cycle characteristics at the population level, we pulsed NPCs with EdU for 30 min and performed flow cytometry analysis 0 or 5 hr later ( Figure S2B ). We found a significant decrease in the percentage of EdU + cells that divided in Mettl14
cKO NPCs compared to WT at 5 hr, confirming a delay in cell-cycle progression ( Figures S2C and S2D ).
Mettl3 Regulates Embryonic Cortical Neurogenesis
Consistent with the finding that Mettl14 is a critical component of the m 6 A methyltransferase complex (Wang et al., 2017) WT and cKO mouse NPCs were electroporated with plasmid co-expressing a Cdk2 sensor (green) and the H2B-mCherry nuclear marker (red), cultured for 2 days, and imaged for 48 hr. Shown in (G) are sample time-lapse images with time stamps. Scale bars, 10 mm. Also shown are boxplots of quantifications for the total cell-cycle length (H; n = 38 for WT and n = 30 for cKO), G 1 phase length (I; n = 20), and S-G 2 -M phase length (J; n = 20). Each dot represents data from one NPC (***p < 0.001; unpaired Student's t test). See also Figure S2 .
from both embryonic mouse cortex in vivo and cultured cortical NPCs ( Figures 3A and 3B A methyltransferase complex (Wang et al., 2017) .
We first confirmed effective Mettl3 knockdown (KD) with qPCR and diminished m 6 A content in mRNAs from Mettl3 KD cells with dot blot analysis (Figures S3A-S3C ; Table S1 ). We next performed population cell-cycle analysis with EdU pulsechase and flow cytometer quantification ( Figure S3D ). We found a significant reduction in the percentage of GFP + EdU + NPCs that divided upon Mettl3 KD ( Figures 3C and 3D ), similar to the effect of Mettl14 cKO ( Figures S2C and S2D) .
To examine the impact of Mettl3 KD on RGC behavior in vivo, we electroporated plasmids co-expressing GFP and the small hairpin RNA (shRNA) against mouse Mettl3, or the control shRNA, in utero at E13.5 and analyzed GFP + cells at E17.5.
Newborn neurons normally migrate toward the cortical plate (CP) through the intermediate zone (IZ), whereas self-renewing RGCs remain in the ventricular zone (VZ) and subventricular zone (SVZ) (Taverna et al., 2014 Values represent mean ± SEM (n = 4; ***p < 0.001; **p < 0.01; unpaired Student's t test). See also Figure S3 . Table S2 ). Similar to previous findings from cell lines (Meyer and Jaffrey, 2014) , our in vivo analysis showed enriched distribution of m 6 A sites near stop codons ( Figure S4B ). We found no correlation between transcript levels and m 6 A tagging ( Figure S4C Table S3 ). We observed m 6 A tagging of a similar group of transcripts in cortical NPCs derived from E13.5 mouse cortex ( Figure S4D ; Table S1 ). See also Figure S4 and Tables S2, S3 , and S4.
To determine the functional consequence of m 6 A tagging, we explored whether Mettl14 deletion affects decay of m 6 A-tagged transcripts. Cortical NPCs derived from E13.5 WT and Mettl14 cKO mice were treated with actinomycin D to halt de novo transcription, and RNA-seq was performed 0 and 5 hr later to obtain the ratio of mRNA levels for each gene in order to measure their stability ( Figure S4E ). Across the transcriptomes, m 6 A-tagged transcripts exhibited significantly lower ratios than non-m 6 Atagged transcripts in the WT NPCs, and this difference was reduced in cKO NPCs ( Figure 4D ; Table S4 ). Direct comparison of WT and Mettl14 cKO NPCs showed that m 6 A-tagged transcripts exhibited a larger increase in their ratios than non-tagged transcripts upon Mettl14 deletion; one m 6 A tag per transcript was sufficient to increase the ratio, and there was a minimal additional effect of more tagging sites ( Figure 4E ). It should be noted that our m 6 A-seq method could not determine whether multiple sites are simultaneously methylated in the same transcript. We confirmed our result with the direct measurement of the half-life of a selected group of transcripts (Figures 4F and S4F; Table S1 ). All together, these results support a model that m 6 A methylation of mRNAs related to the cell cycle and neurogenesis confers their rapid turnover during the dynamic progress of cortical neurogenesis; a lack of m 6 A-tagging attenuates the decay of these mRNAs, resulting in deficits in temporal specification and cell-cycle progression of NPCs.
Mettl14 Deletion Uncovers Transcriptional Prepatterning for Normal Cortical Neurogenesis
Among the 2,059 m 6 A-tagged genes in the E13.5 mouse cortex, two major GO terms were generation of neurons and neuronal differentiation ( Figure 4C ). For example, the IPC markers Tbr2 and Neurog2 and the neuronal markers Neurod1 and Neurod2 (Hevner et al., 2006) were m 6 A tagged in E13.5 forebrain in vivo ( Figure 5A ) and in cultured cortical NPCs ( Figure S4D ). qPCR analysis of total mRNA showed increased levels of Tbr2, Neurog2, Neurod1, and Neurod2, but not non-tagged Rad17, in Mett14 cKO compared to WT NPCs ( Figure 5B ; Table S1 ). This result raised the possibility that neuronal lineage genes are already expressed in neural stem cells and their levels are actively suppressed post-transcriptionally by m 6 A-dependent decay; alternatively, Mettl14 deletion may transcriptionally upregulate these neuronal genes.
To differentiate between these two possibilities, we quantified the levels of nascent mRNA using the 4-thiouridine (4sU) metabolic labeling approach (Duffy et al., 2015) . We found comparable and even lower levels of nascent mRNA of neuronal lineage genes, such as Tbr2, Neurog2, and Neurod2, in Mettl14
NPCs in comparison to WT NPCs ( Figure 5B ; Table S1 ). The lower levels of nascent mRNA observed for some neuronal lineage genes in Mettl14 cKO NPCs could be explained by a negative feedback loop at the level of transcription, originating from elevated expression of stem cell genes, such as Emx2 and Sox1 ( Figure 5B ). Similarly, we found comparable levels of premRNA for neuronal lineage genes in Mettl14 cKO and WT NPCs ( Figure S5A ; Table S1 ), suggesting that the increase in the total mRNA of neuronal lineage genes in Mettl14 cKO NPCs is not due to transcriptional upregulation. Together, these results support that neuronal lineage genes are already expressed in neural stem cells under normal cortical neurogenesis. Consistent with our result, mining the published single-cell RNAseq dataset (Telley et al., 2016) (Telley et al., 2016) , these results suggest that Mettl14 regulates neuronal lineage gene expression directly in RGCs.
To further assess our model that mRNA decay regulates neuronal lineage gene expression in RGCs, we performed in vivo KD experiments for the components of the CCR4-NOT complex (Cnot7 and Cnot1), a major cytoplasmic mRNA deadenylase complex responsible for mRNA decay (Du et al., 2016; Schoenberg and Maquat, 2012 5F ). Taken together, our results suggest heightened transcriptional coordination and a previously unappreciated transcriptional prepatterning mechanism for mammalian cortical neurogenesis in which late IPC and neuronal genes are already transcribed in cortical neural stem cells and these transcripts are downregulated post-transcriptionally by m 6 A-dependent decay.
METTL14 Regulates Cell-Cycle Progression of Human Cortical NPCs
We next examined whether m 6 A function is conserved in human cortical neurogenesis. Using a previously developed protocol , we differentiated human iPSCs into a highly pure population of NESTIN + SOX2 + NPCs (hNPCs; 96.4% ± 1% among all cells; n = 5; Figure S6A ). We co-expressed GFP and the validated shRNA against human METTL14 in these hNPCs ( Figure S6B ). After 4 days, we labeled cells with EdU for 30 min and performed cell cycle analysis with flow cytometer quantification 14 hr later ( Figure S6C ). Similar to results from mouse Mettl14 cKO NPCs ( Figures S2C and S2D ), we found a significant decrease in the percentage of GFP + EdU + hNPCs that divided with METTL14 KD, indicating a delayed cell-cycle progression ( Figures 6A and 6B) .
We recently developed a human-iPSC-derived forebrain organoid model, which exhibits transcriptome profiles similar to fetal human cortex during development up to the second trimester See also Figure S5 . . Around day 47, these forebrain organoids resemble mouse cortical neurogenesis at E13.5 ( Figure S6D ). We microinjected plasmids co-expressing GFP and the shRNA against human METTL14, or the control shRNA, into the lumen of forebrain organoids and performed electroporation to transfect RGCs ( Figure S6E ). After 7 days, we pulsed organoids with EdU for 1 hr and performed cell-cycle analysis of GFP + cells 14 hr later ( Figure S6F ). We observed a significant decrease in the percentage of GFP + EdU + cells that divided with METTL14 KD ( Figures 6C and 6D ). Together, these results indicate that m 6 A mRNA methylation plays a conserved role in regulating cortical NPC cell cycle progression in both mouse and human. A peaks associated with 4,702 transcripts ( Figure S7A ; Table S2 ). Our previous systematic RNA-seq analyses of human forebrain organoids at different stages revealed that transcriptomes of organoids around day 47 were similar to human fetal cortex at 8-12 post-conception weeks (PCW) . We further performed m 6 A-seq of PCW11 fetal human brain and identified 10,980 high-confidence peaks associated with 5,049 transcripts ( Figure S7B ; Table S2 ). m 6 A sites were enriched near transcription start sites and stop codons for both human samples ( Figures S7C and S7D) . Furthermore, m 6 A profiles from both samples showed significant overlap ( Figure 7B ). GO analysis of m 6 A-tagged transcripts shared in both samples showed enrichment of genes related to neurogenesis, neuronal differentiation, and development ( Figure 7C ; Table S5 ).
Many recently identified risk genes for schizophrenia and autistic spectrum disorders have been shown to be dynamically expressed and play critical roles during mammalian embryonic brain development (Ohi et al., 2016; Tebbenkamp et al., 2014) . Notably, disease ontology analysis of these m 6 A-tagged genes shared in both human samples showed enrichment related to mental disorders, mental retardation, schizophrenia, and bipolar disorder ( Figure 7C ; Table S5 ).
We further performed comparison among m 6 A landscapes during mouse and human cortical neurogenesis. Approximately 19.3%, 34.7%, and 31.4% of detected transcripts exhibited m 6 A tagging in E13.5 mouse brain, day 47 human forebrain organoids, and PCW11 human fetal brain, respectively ( Figure S7E ). Therefore, m 6
A mRNA methylation appears to be more prevalent in human. Among transcripts expressed in all three samples, 856 genes were commonly m 6 A tagged ( Figure 7D ). These commonly m 6 A-tagged transcripts are enriched for genes related to neurogenesis and neuronal differentiation ( Figure S7F ; Table S5 ). Notably, 1,173 transcripts were expressed in both species, but only m 6 A-tagged in both human samples (Figure 7D ). Ontology analysis of these human-specific m 6 A-tagged transcripts showed enrichment of genes related to mental disorders and mental retardation (Figures 7E and 7F ; Table S5 ). Among genes associated with the 108 loci recently identified for genetic risk of schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), 60 genes were m 6 A tagged in human and 21 genes were uniquely tagged in both human forebrain organoids and fetal brain, but not in mouse E13.5 forebrain. On the other hand, the gene set of m 6 A-tagged transcripts shared between mouse and human is enriched for oncogenic processes ( Figure 7E) . (C and D) Flow cytometry analysis of cell cycle progression with METTL14 KD in human forebrain organoids. Day 45 forebrain organoids were electroporated to co-express GFP and shRNAcontrol or shRNA-METTL14. After 7 days, forebrain organoids were pulse-labeled with EdU (10 mM) for 1 hr and cultured further for 14 hr, followed by dissociation. Shown are sample histograms of DNA content from GFP + EdU cell sand the total population (C) and quantification (D).
Values represent mean ± SEM (n = 4; ***p < 0.001; unpaired Student's t test). See also Figure S6 .
DISCUSSION
From flies to mammals, neurogenesis is a highly coordinated process with sequential waves of gene expression (Kohwi and Doe, 2013) . Here, we revealed a critical role of m 6 A mRNA methylation in this process in the mammalian system in vivo.
Our results suggest a model in which m 6 A tagging of transcripts related to neural stem cells, the cell cycle, and neuronal differentiation confers their rapid turnover to control the transcriptome composition at different phases of the dynamic cortical neurogenesis process. The observation of RGCs expressing markers thought to be expressed only in late IPCs and post-mitotic neurons in Mettl14 cKO mice led to the discovery of transcriptional prepatterning in normal cortical neurogenesis and identifies m 6 A mRNA methylation as a key mechanism to prevent precocious expression of genes of later lineage status at the protein level in stem cells. We also provide the emerging ''epitranscriptomics'' field with databases of m 6 A mRNA landscapes of mouse and human cortical neurogenesis and identify intriguing humanspecific features.
Transcriptional Prepatterning for Cortical Neurogenesis
The concept of prepatterning initially came from analysis of chromatin states within multipotent progenitors to regulate the fate choice for liver and pancreas (Xu et al., 2011 A-tagged transcripts showed enrichment for oncogenic processes (E, bottom). See also Figure S7 and Tables S2 and S5. prepatterning is important for spatio-temporal regulation of gene expression and may be a widespread phenomenon in cell fate decision (Chen and Dent, 2014) . Our study reveals transcriptional prepatterning in normal cortical neural stem cells in vivo. Consistent with our model, Pax6 has been shown to bind and activate both Tbr2 and Neurod1 promoters (Sansom et al., 2009) . We showed that prepatterning transcripts are tagged with m 6 A and subjected to rapid decay; therefore, most of them are present in low levels among the bulk mRNA preparation and little protein under normal conditions, a likely reason why such a mechanism has escaped detection in previous studies. While epigenetic mechanisms play a key role in transcriptional regulation during neurogenesis , epitranscriptomic regulation as a post-transcriptional mechanism could provide the speed and additional specificity while maintaining plasticity of gene expression. By working in concert, the epigenetic landscape can permit transcription of certain genes, such as genes defining late lineage states, while the epitranscriptome prevents aberrant protein production. Future studies are needed to investigate whether transcriptional prepatterning is a general mechanism in fate specification of other stem cells during development.
Heightened Transcriptional Coordination of Mammalian Cortical Neurogenesis by m 6
A Our study provides the in vivo evidence in the mammalian system to support the emerging notion that m 6 A methylation plays a critical role in developmental fate transition. The precise and predictable developmental schedule of cortical neurogenesis requires rapid, tightly controlled changes in gene expression (Okano and Temple, 2009 and human samples are enriched with genes related to neural stem cells, the cell cycle, and neurogenesis. Notably, many genes associated with genetic risk for mental disorders, such as schizophrenia and autistic spectrum disorders, are m 6 A tagged in humans, but not in mice, raising the possibility that epitranscriptomic dysregulation may contribute to these human brain disorders. So far, one association study found evidence of ALKBH5 in conferring genetic risk for major depression disorder (Du et al., 2015) , and two studies identified an association between FTO mutations and growth retardation and developmental delay (Boissel et al., 2009; Daoud et al., 2016) .
In summary, our study identifies a critical and conserved role of an m 6 A epitranscriptomic mechanism in the temporal control of mammalian cortical neurogenesis via promotion of mRNA decay of transcripts related to transcription factors, neural stem cells, the cell cycle, and neuronal differentiation. Future studies will address how this epitranscriptomic mechanism interacts with various epigenetic mechanisms to coordinate dynamic transcriptomes during brain development and how dysregulation of epitranscriptomic mechanisms may contribute to brain disorders.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
Exons 7, 8, and 9 of mouse Mettl14 were targeted by inserting a single loxP site in intron 6 and an FRT-flanked neomycin resistance gene coupled with a loxP site in intron 9, with the consideration that they contain the DPWW active motif ( Figure S1B ). The targeting construct was electroporated into 129 mESCs, selected for neomycin resistance, screened for homologous recombination by Southern blotting, and selected mESC clones were used to generate chimeric mice by injection into C57BL/6J mouse blastocysts. For in utero electroporation analysis, timed-pregnant CD1 mice (Charles River Laboratory) at E13.5 were used as previously described . Timed pregnant mice were euthanized by cervical dislocation, and embryos were euthanized by decapitation before the dissection step. All animal procedures used in this study were performed in accordance with the protocol approved by the Institutional Animal Care and Use Committee of Johns Hopkins University School of Medicine.
Primary mouse NPCs
Mouse NPCs were isolated from Mettl14 WT and cKO mouse embryonic cortices and cultured in Neurobasal medium (GIBCO BRL) containing 20 ng/ml FGF2, 20 ng/ml EGF, 5 mg/ml heparin, 2% B27 (v/v, GIBCO BRL), Glutamax (Invitrogen), Penicillin/Streptomycin (Invitrogen) on culture dishes precoated with Matrigel matrix (2%, Corning).
Human iPSC cultures and fetal brain sample
The human iPSC line used in the current study (C1) was fully characterized Yoon et al., 2014) . iPSCs were cultured in stem cell medium, consisting of DMEM:F12 (Invitrogen) supplemented with 20% Knockout Serum Replacer (GIBCO), 1X Nonessential Amino Acids (Invitrogen), 1X Penicillin/Streptomycin (Invitrogen), 1X 2-Mercaptoenthanol (Millipore), 1X Glutamax (Invitrogen), and 10 ng/ml FGF-2 (Peprotech). Culture medium was changed every day. Human iPSCs were passaged every week onto a new plate preseeded with irradiated CF1 mouse embryonic fibroblasts (Charles River Laboratory). Human iPSCs were detached from the plate by treatment of 1 mg/ml Collagenase Type IV (Invitrogen) for 1 hr. iPSC colonies were further dissociated into smaller pieces by manual pipetting. All studies were performed under approved protocols of Johns Hopkins University School of Medicine. Human iPSCs were differentiated into primitive hNPCs according to a previously published protocol (Li et al., 2011) . Briefly, iPSCs were passaged onto MEF feeders, and after 3 days, induction medium containing Advanced DMEM:F12 (50%) and Neurobasal medium (50%), CHIR99201 (4 mM, Cellagentech), SB431542 (3 mM, Cellagentech), Bovine serum albumin (5 mg/ml, Sigma), hLIF (10 ng/ml, Millipore), Compound E (0.1 mM, EMD Millipore), Glutamax (Invitrogen), Pen/Strep, supplemented with N2 and B27 (Invitrogen), was added to the culture. After 6 days of differentiation, hNPCs were dissociated with Accutase (Invitrogen) and plated, with the aid of a ROCK inhibitor (Y-27632, 3 mM, Cellagentech), onto culture dishes precoated with Matrigel matrix (2%, Corning).
The PCW11 fetal human cortical tissue was used for m 6 A-seq. All procedures used in this study were performed in accordance with the protocol approved by the Institutional Stem Cell Research Oversight Committee of Johns Hopkins University School of Medicine and Lieber Institute for Brain Development.
METHOD DETAILS
DNA constructs
For KD experiments for mouse genes, short hairpin RNA sequences (see Key Resources Table) were cloned into the retroviral vector expressing GFP under the control of the EF1a promoter and a specific shRNA under the control of human U6 promoter (pUEG) as previously described (Ge et al., 2006) . For KD experiments for human METTL14, a short hairpin RNA sequence was cloned into the lentiviral vector expressing GFP under the control of the human ubiquitin C promoter and the specific shRNA under the control of human U6 promoter (cFUGW: Addgene plasmid 14883) as previously described . The efficacy of each shRNA was confirmed in mouse B16-F10 cells (ATCC), or hNPCs derived from the C1 iPSC line.
In utero electroporation and FlashTag
In utero electroporation was performed as described previously . In brief, timed-pregnant CD1 mice (Charles River Laboratory) at E13.5 or E14.5 were anesthetized and the uterine horns were exposed and approximately 1 to 2 mL of plasmid DNA, 0.5 mg/ml pCAG-GFP (Addgene plasmid: 11150) and 2.5 mg/ml cFUGW plasmid with the control shRNA, or the shRNA against mouse Mettl3, Cnot1 and Cnot7, was injected manually into the lateral ventricles of embryos using a calibrated micropipette. Five pulses (40 V, 50 ms in duration with a 950 ms interval) were delivered across the uterus with two 5-mm electrode paddles (CUY650-5, Nepa Gene) positioned on either side of the head by a square wave electroporator (CUY21SC, Nepa Gene). After electroporation, the uterus was placed back in the abdominal cavity and the wound was sutured. Mouse embryos were analyzed at E17.5. For FlashTag of RGCs, 1 mL of 10 mM of a carboxyfluorescein succinimidyl ester (CellTrace CFSE, ThermoFisher) was injected into the lateral ventricle of the E17.5 embryos using a calibrated micropipette. Mouse embryos were collected 3 hr later, fixed with 4% paraformaldehyde in PBS overnight at 4 C for analysis. All animal procedures were performed in accordance with the protocol approved by the Johns Hopkins Institutional Animal Care and Use Committee.
Immunohistology and confocal imaging
For EdU labeling, timed pregnant mice were injected with EdU (150 mg/kg bodyweight, Invitrogen) at defined time points before euthanasia. For immunostaining of tissue sections, brains were fixed with 4% paraformaldehyde in PBS overnight at 4 C as previously described . Samples were cryoprotected in 30% sucrose in PBS, embedded in OCT compound, and sectioned coronally (20 mm-thickness) on a Leica CM3050S cryostat. Brain sections were blocked and permeabilized with the blocking solution (5% normal donkey serum, 3% Bovine serum albumin, and 0.1% Triton X-100 in PBS) for 1 hr at room temperature, followed by incubation with primary antibodies diluted in the blocking solution at 4 C overnight. After washing, secondary antibodies diluted in blocking solution were applied to the sections for 1 hr at room temperature. Nuclei were visualized by incubating for 10 min with 0.1 mg/ml 4,6-diamidino-2-phenylindole (DAPI, Thermo Fisher Scientific) in PBS. For EdU labeling, Click-iT EdU Alexa Fluor 647 Imaging Kit (Thermo Fisher Scientific) was used following the manufacturer's protocol . Stained sections were mounted with ProLong Gold anti-fade reagents (Thermo Fisher Scientific) and analyzed. All the antibodies used are listed in the Key Resources Table. Mouse and human NPC electroporation Approximately 1.0 X 10 6 mouse or human NPCs were resuspended in 100 mL Mouse Neural Stem Cell Nucleofector Solution from the Lonza Nucleofector Kit for Mouse Neural Stem Cells (Lonza, VAPG-1004). Additionally, 10 mg of the appropriate plasmid was added to the cell solution. The solution was then placed in a cuvette provided in the Nucleofector Kit and electroporated using a Lonza Nucleofector 2b device (LONZA) (Ma et al., 2008) . Next, the cells were resuspended in NPC media as described above with Rock Inhibitor (Y-27632, 3 mM, Cellagentech) to reduce cell death. Cells were allowed to grow for at least 3 days before analysis.
Human forebrain organoid culture Protocols for generation of forebrain organoids were detailed previously Xu et al., 2016; Yoon et al., 2017) . Briefly, human iPSCs were cultured in stem cell medium, consisting of DMEM:F12 (Invitrogen) supplemented with 20% Knockout Serum Replacer (GIBCO), 1X Non-essential Amino Acids (Invitrogen), 1X Penicillin/Streptomycin (Invitrogen), 1X 2-Mercaptoenthanol (Millipore), 1X Glutamax (Invitrogen), and 10 ng/ml FGF-2 (Peprotech) on irradiated CF1 mouse embryonic fibroblasts (Charles River). On day 1, iPSC colonies were detached by treatment of 1 mg/ml Collagenase Type IV (Invitrogen) for 1 hr and transferred to an Ultra-Low attachment 6-well plate (Corning Costar), containing 3 mL of stem cell medium (without FGF-2), plus 2 mM Dorsomorphine (Sigma) and 2 mM A83-01 (Tocris). On days 5-6, half of the medium was replaced with induction medium consisting of DMEM:F12, 1X N2 Supplement (Invitrogen), 1X Penicillin/Streptomycin, 1X Non-essential Amino Acids, 1X Glutamax, 1 mM CHIR99021 (Cellagentech), and 1 mM SB-431542 (Cellagentech). On day 7, organoids were embedded in Matrigel (Corning) and continued to grow in induction medium for 6 more days. On day 14, embedded organoids were mechanically dissociated from Matrigel and transferred to each well of a 12-well spinning bioreactor (SpinU) containing differentiation medium, consisting of DMEM:F12, 1X N2 and B27 Supplements (Invitrogen), 1X Penicillin/Streptomycin, 1X 2-Mercaptoenthanol, 1X Non-essential Amino Acids, 2.5 mg/ml Insulin (Sigma).
Forebrain organoid electroporation and analysis
Day 45 forebrain organoids were transferred into PBS solution in a 10 cm petri dish for electroporation. A mixture of 0.5 mL of plasmid DNA and 0.05% Fast green was injected into the lumen of neural tube structures in forebrain organoids using a calibrated micropipette (Yoon et al., 2017) . About 3-4 locations on one side of each forebrain organoid were targeted by the injection. The DNA-injected side of the organoid was placed toward the positive electrode in the middle of 5 mm gap of electrode paddles (CUY650-5, Nepa Gene). Five pulses (40 V, 50 ms in duration with a 950 ms interval) were delivered by a square wave electroporator (CUY21SC, Nepa Gene). After electroporation, organoids were transferred back to the SpinU bioreactor for further culturing.
Analysis of cell cycle progression by EdU pulse labeling
Analyses of cell cycle progression of mouse NPCs, hNPCs, and dissociated human forebrain organoids were performed as described previously (Terry and White, 2006; Wang et al., 2014b) . In brief, mouse or human NPCs were pulsed by 10 mM EdU (ThermoFisher) for 30 min and washed thoroughly with NPC media. For human forebrain organoids, 10 mM EdU directly applied to culture media and organoids were incubated in the SpinU bioreactor for 1 hr to ensure complete penetrance, then washed thoroughly with culture media. After defined time points, cells were dissociated by Accutase, fixed with 4% paraformaldehyde in PBS for 20 min at 4 C, stained with Click-iT EdU Alexa 647 Flow Cytometry Kits (ThermoFisher) or Click-iT EdU Alexa 488 Flow Cytometry Kits (ThermoFisher) for Flow Cytometry following manufacturer's protocol. Cells were stained with Vybrant DyeCycle Violet (ThermoFisher) or 7-AAD (ThermoFisher) for DNA content and applied to flow cytometry using BD LSR II Flow Cytometer (BD Bioscience). EdU + or GFP + EdU + cells were gated and DNA content of those cells was analyzed compared to that of whole cell population. Percentages of divided cells among EdU + or GFP + EdU + population (G 1 or G 0 phase determined by DNA content) during defined time intervals were quantified from four independent experiments. Time-lapse live imaging of mouse NPCs 96-well glass bottom microplates (655892, Geiner bio-one) were coated with phenol red-free Matrigel (356237, Corning). After electroporation of mNPCs with 10 mg CDK2-sensor plasmid (pPGK-H2B-mCherry-DHB (aa994-1087)-GFP), cells were plated onto the microplates at a density of 3,000 cells per well and allowed to adhere overnight. Cells were imaged using a Nikon Eclipse Ti fluorescent microscope controlled by Metamorph microscopy automation software. Temperature (37 C), CO 2 (5%), and humidity were held constant throughout experiments. Five blank positions in a well containing Matrigel and media only were used to flat field mNPC images using custom software. ImageJ was used to merge the green and red channels. To quantify the total cell cycle length, time was measured from the first cell division to the next cell division of one or both daughters. To quantify the G 1 phase length, time was measured from one cell division to the time point of significant reduction in the ratio of green/red intensity in the nucleus of the cell. S phase entry was quantitatively defined as the time when the cytoplasmic/nuclear ratio of green/red was approximately 1, as previously described (Spencer et al., 2013) . A nuclear marker, H2B-mCherry, was used in the plasmid sensor to accurately segment the cytoplasm and the nucleus. The time point from S phase entry through the second cell division was then quantified as S-G 2 -M length.
RNA purification and quantitative RT-PCR analysis
For gene expression analysis, total RNA fraction was isolated from cultured NPC samples with RNeasy Mini Kit (QIAGEN), treated with DNaseI and reverse-transcribed into the first-strand cDNA with SuperScript III (Invitrogen). cDNAs were used for SYBR-green based quantitative real-time PCR to measure the expression level of target genes with the T method (ABI). All the primers used for quantitative PCR were listed in Table S1 .
Western blot analysis
Forebrains from E17.5 embryos were quickly dissected out and homogenized in RIPA buffer (50 mM Tris pH 7.5, 120 mM NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 5 mM EDTA, Phosphatase Inhibitor Cocktail (Cell Signaling), protease inhibitor cocktail (Sigma). Lysates were incubated for 15 min on ice and centrifuged at 15,000 g for 15 min at 4 C. Supernatant was collected and boiled for 5 min in Laemmli sample buffer (Bio-Rad), resolved by SDS-PAGE, transferred to PVDF membrane, and immunoblotted. Primary antibodies are listed in KEY RESOURCE TABLE. Quantification of bands was performed using ImageJ software. A dot blot assay mRNA was harvested from homogenized forebrains at embryonic stages E15.5 and E17.5 using Dynabeads mRNA Direct Purification Kit (61011, Ambion). Four biological replicates were pooled for each sample to ensure sufficient concentration of mRNA. Dots were applied to an Amersham Hybond-N + membrane (GE Healthcare) in duplicate as 100 ng mRNA per 1 mL dot. After complete drying, the mRNA was crosslinked to the membrane using a UV Stratalinker 2400 by running the auto-crosslink program twice. The membrane was then washed in PBST three times and blocked with 5% skim milk in PBST for 2 hr. The PBST wash was repeated and the membrane was incubated with primary anti-m 6 A antibody (212B11, Synaptic Systems) at 1:1000 dilution for 2 hr at room temperature. After 3 washes in PBST, the membrane was incubated in HRP-conjugated anti-mouse IgG secondary antibody for 2 hr at room temperature, then washed again 3 times in PBST. Finally, the membrane was visualized using SuperSignal West Dura Extended Duration Substrate (34075, Thermo Scientific). To confirm equal mRNA loading, the membrane was stained with 0.02% methylene blue in 0.3 M sodium acetate (pH 5.2) and quantified m 6 A levels were normalized to amount of mRNA loaded.
Four biological samples in technical duplicates for each time point were used.
A-sequencing m 6 A profiling was performed as previously described (Dominissini et al., 2012) . For m 6 A profiling of mouse developing brain, forebrains from WT E13.5 embryos were dissected. For m 6 A profiling of human organoids, 25 to 30 forebrain organoids at day 47 were used. For m 6 A profiling of PCW11 fetal human brain, cortex from 2 PCW11 fetuses were dissected. The total RNA was extracted using RNeasy Mini Kit (QIAGEN). mRNA was isolated using the Dynabeads mRNA Purification Kit (Invitrogen) and mRNA was fragmented via sonication to 100-200 base pairs. m 6 A pull-down was performed using a rabbit polyclonal anti-m 6 A antibody (Synaptic systems), and immunoprecipitation with protein G dynabeads (ThermoFisher). m 6 A-tagged mRNAs were competitively eluted from beads with free N 6 -methyladenosine. cDNA libraries from pulled-down RNA and input RNA were prepared using the NEBNext Ultra RNA Library Prep Kit for Illumina. The experiment was performed with three technical replicates. For m 6 A profiling of day 47 human forebrain organoids, the same procedure was followed, with the exception that the experiment was performed with two technical replicates because of the amount of samples required.
A mRNA immunoprecipitation and Q-PCR Total RNA from NPCs cultured from WT E13.5 mouse forebrain was extracted using RNeasy Mini Kit (QIAGEN) and mRNA was isolated using the Dynabeads mRNA Purification Kit (Invitrogen). 1% of input mRNA was reserved for reverse transcription. Fulllength m 6 A tagged transcripts were pulled-down using a rabbit polyclonal anti-m 6 A antibody (Synaptic systems) and a mock pull-down was done with normal rabbit IgG (Cell Signaling Technologies). Immunoprecipitation was performed with protein G dynabeads (Thermo Fisher). m 6 A-tagged mRNAs were competitively eluted from beads with free N 6 -methyladenosine. ) and dividing each concentration by the relative concentration of the input. The concentrations of the immunoprecipitated RNA were then divided by the concentration in the input RNA and multiplied by 100, to obtain the percentage of transcripts in the m 6 A immunoprecipitation relative to the input. This value was then normalized to enrichment in the mock (IgG) pull-down, which was also calculated using relative concentrations to determine a percentage of the input. Primers used are listed in Table S1 .
Bioinformatic analyses of m 6
A-seq cDNA libraries from input and m 6 A pull-down were sequenced on the Illumina Nextseq platform, using a 50-cycle single-end run.
Preprocessing of reads was performed using the FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), namely adapters were clipped, poor quality reads were filtered out, and identical reads were collapsed. Preprocessed reads from E13.5 mouse forebrains were aligned to the mouse genome (build GRCm38/mm10), and reads from the human organoids and fetal brain to the human genome (build GRCh37/hg19), using Tophat2 (Kim et al., 2013) with default settings. m 6 A-tagged regions were identified using the MACS2 peak calling algorithm (Zhang et al., 2008) , with the input library as background. For identifying high confidence m 6 A regions, peaks were intersected in a pairwise fashion among all replicates using the BedTools package (Quinlan and Hall, 2010) . Peaks that overlap in at least 50% of their length among 2 or more samples were designated as high confidence m 6 A regions.
For representative coverage plots of m 6 A and input libraries, RNA-seq read alignments in bam format were transformed to bedGraph format and normalized for library size using the genomecov function from the BedTools package (Quinlan and Hall, 2010) . Analysis of m 6 A peak enrichment was performed based on 5 non-overlapping transcript segments defined as follows: . Each high confidence peak was annotated to one of these regions using the BedTools package and fold enrichment was calculated from the ratio between observed peaks per region and expected number of peaks normalized by average region size. For analysis of correlation between gene expression levels and m 6 A peak fold change, we calculated RPKMs from input RNA seq libraries, using gene counts obtained with the htseq-count function from the HTSeq python package (Anders et al., 2015) that were normalized by library size and gene length defined as the length of its longest transcript. Fold changes for m 6 A peaks were obtained from MACS2 output.
Functional annotation and disease ontology
To assess enrichment of GO terms specific to a biological process, the ToppFunn module of the ToppGene Suite (Chen et al., 2009) was used. A hypergeometric probability mass function with Benjamini Hochberg FDR correction was used to identify significant enrichment for GO terms. Analysis of enrichment for Wikipathways terms was performed using ConsensusPathDB (Herwig et al., 2016) , which calculates enrichment p values using the Wilcoxon's matched-pairs signed-rank test, and Benjamini Hochberg FDR correction. Disease association analysis was performed using WebGestalt (Zhang et al., 2005) , which uses a hypergeometric method and Benjamini Hochberg FDR correction. Protein interaction network figures were generated using Cytoscape 3.3.0 (Shannon et al., 2003) , with the Reactome FI plugin.
RNA degradation assay cDNA libraries were prepared from cultured NPCs from E13.5 WT and Mettl14 cKO cortex, at 0 and 5 hr post Actinomycin D treatment, using the NEBNext Ultra RNA Library Prep Kit for Illumina. The experiment was performed with three replicates per condition. Sequencing was performed on the Illumina Nextseq platform, using a 100-cycle single-end run. Preprocessing of reads was performed using the FASTX toolkit. Gene expression levels were quantified using the RSEM package (Li and Dewey, 2011), which maps reads to the transcriptome using the aligner tool Bowtie2 (Langmead and Salzberg, 2012) . Expected counts per gene per sample were combined into a count matrix, and this matrix was used as input for differential expression analysis using the EBSeq package (Leng et al., 2013) , which uses empirical Bayesian methods to calculate the posterior probability of a gene being differentially expressed (PPDE). Posterior fold changes per gene between cKO and WT were obtained at time 0 and 5 hr after Actinomycin D treatment. Fold changes at 5 hr were normalized by fold changes at 0 hr (no Actinomycin D treatment) to specifically identify genes that degrade at a different slower rate in the cKO compared to WT, regardless of baseline changes in gene expression between two conditions. Genes with a normalized fold change higher than 2 in cKO over WT at 5 hr were considered to be differentially degraded (Table S4) .
Half-life measurement of m 6 A-tagged transcripts Mouse NPCs were cultured in standard 6 well culture plates to approximately 80% confluence. Actinomycin D (Sigma) was added at a concentration of 5 mM. Cells were collected at three time points after addition (0, 3 hr, 5 hr) by washing once with PBS, then lysing the cells in Buffer RLT from the RNeasy Kit (QIAGEN) with 1% b-Mercaptoethanol. A cell scraper was used to remove all cells from the well plate. Each sample was normalized for cell number by quantifying DNA content using a Quant-IT PicoGreen dsDNA Assay Kit (ThermoFisher) according to manufacturer instructions. Equal amounts of cellular contents, as measured by DNA quantity, were taken from each sample and 1 pg of luciferase control RNA (Promega) was added to each sample before RNA purification. Total RNA was then purified using an RNeasy Kit and reverse transcribed using the SuperScript II First-Strand Synthesis System (Thermo Fisher). Real-time PCR was performed on a Step One Plus cycler from Applied Biosystems with Fast SYBR Green Master Mix. Standard curves were generated by plotting CT values against the known initial concentration of luciferase control RNA, and then used to derive mRNA concentration of each target gene at each time point. The ln mRNA concentrations at time point 0, 3 and 5 hr were then used to perform a linear regression as a function of time, and identify the slope of said line as the decay rate (k) ( Figure S4F ). Half life was calculated with the following formula: t1/2=ln2/kdecay = ln2/k decay (Chen et al., 2008) .
Metabolic labeling and purification of nascent RNA 4sU labeling of nascent RNA was performed as previously described (Duffy et al., 2015) . Mouse NPCs from E13.5 WT and Mettl14 cKO forebrain were cultured in standard 6 well culture plates to approximately 80% confluence, treated with 500 mM of 4sU (Carbosynth) for 1 hr, washed with PBS, and harvested with TRIzol reagent (ThermoFisher). Samples were extracted by chloroform twice and precipitated with isopropanol. Biotinylation of 4sU-RNA were carried out in a total volume of 250 ml, containing 70 mg total RNA, 10 mM HEPES (pH 7.5), 1 mM EDTA, and 5 mg MTSEA biotin-XX (Biotium) freshly dissolved in DMF (final concentration of DMF = 20%). Reactions were incubated at RT for 30 min in the dark, and excess biotin reagents were removed by chloroform extraction twice. Purified RNA was dissolved in 50 mL RNase-free water and denatured at 65 C for 10 min, followed by rapid cooling on ice for 5 min. Biotinylated RNA was separated from non-labeled RNA by incubating with 100 mL Streptavidin Magnetic Beads (ThermoFisher) for 20 min at RT. Beads were washed twice with high-salt wash buffer (500 mL each, 100 mM Tris-HCl pH 7.4, 10 mM EDTA, 1 M NaCl, and 0.1% Tween-20). 4sU-RNA was eluted with 100 mL freshly prepared 100 mM DTT followed by a second elution with an additional 100 mL 5 min later. RNA was recovered using the MinElute Spin columns (QIAGEN) according to the instructions of the manufacturer, and applied for Q-PCR analysis.
Comparison between human and mouse m 6 A-seq datasets For comparison of m 6 A sequencing data from day 47 human forebrain organoids, PCW11 fetal human cortex, and mouse E13.5 forebrains, we restricted our analysis to expressed genes with a one-to-one ortholog between species. For determining expressed genes, we calculated RPKMs (as stated above) from input libraries, and used a threshold of RPKM > 1.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data in figure panels reflect several independent experiments performed on different days. An estimate of variation within each group of data is indicated using standard error of the mean (SEM).
We performed unpaired Student's t test for assessing the significance of differences between two treatments (See each figure for details).
Analyses of mouse cortical neurogenesis in vivo
For quantitative analysis of electroporated neocortices, only GFP + cells localized within the dorso-lateral cortex were examined.
3 3 3 tiled images were obtained to cover the electroporated region of each coronal section with a 20x or 40x objective by scanning microscope (Zeiss LSM 800) and compared with equivalent sections in littermate counterparts. Quantifications were performed using Imaris software (Bitplane). Specifically, for quantification of cell fate after in utero electroporation, GFP + cells were marked, and GFP + Pax6 + cells were defined and counted based on the intensity of Pax6 immunofluorescence in GFP + cells measured with the same criteria among different groups using Imaris software. For the distribution of GFP + cells in each layer, the borders between different layers were defined by Pax6 immunofluorescence (VZ/SVZ) and DAPI staining (SVZ/IZ and IZ/CP). For quantification of cell fate in WT and Mettl14 cKO mice at E17.5, P0 and P5, the regions of the primary somatosensory cortex were identified and the numbers of Pax6 + , Tbr2 + , S100b + , Ctip2 + , Satb2 + or Tbr1 + cells were counted in each vertical column with 100 mm width. For distribution plots, the distances between soma of EdU every 20 mm interval from the ventricular surface were plotted as density distribution. All quantifications were performed with 4-10 brain sections from at least 4 animals. Data are presented as the mean ± SEM and statistical significance was assessed using unpaired Student's t test.
DATA AND SOFTWARE AVAILABILITY
The access number for the data for m 6 A-seq reported in this study is NCBI GEO: GSE99017.
